Cholestyramine

Product NDC: 49884-466
Requested package NDC: 49884-466-65
11-digit product format: 498840466
Labeler code: 49884
Product ID: 49884-466_587586f5-0b75-4dc8-b78d-477a66e0cb30
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: cholestyramine
Dosage form: POWDER, FOR SUSPENSION
Route: ORAL
Labeler: Par Health USA, LLC
Application: ANDA077203
Marketing category: ANDA
Marketing start: 2005-09-15
Substance: CHOLESTYRAMINE
Active strength: 4 g/5g
Pharmacologic classes: Bile Acid Sequestrant [EPC], Bile-acid Binding Activity [MoA]
NDC exclude flag: No
Listing certified through: 2027-12-31
Current FDA listing: Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
A077203-001	CHOLESTYRAMINE LIGHT	CHOLESTYRAMINE	EQ 4GM RESIN/PACKET	POWDER / ORAL	AB		2005-08-26
A077203-002	CHOLESTYRAMINE LIGHT	CHOLESTYRAMINE	EQ 4GM RESIN/SCOOPFUL	POWDER / ORAL	AB		2005-08-26

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 2 matching rows.

Application-product, TE code table
Application-product	TE code
A077203-001	AB
A077203-002	AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 3 · 86 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-09-14 22:38:34	2026-08	A077203-001	CHOLESTYRAMINE LIGHT	EQ 4GM RESIN/PACKET	POWDER / ORAL	AB	2005-08-26	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A077203-002	CHOLESTYRAMINE LIGHT	EQ 4GM RESIN/SCOOPFUL	POWDER / ORAL	AB	2005-08-26	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	A077203-001	CHOLESTYRAMINE LIGHT	EQ 4GM RESIN/PACKET	POWDER / ORAL	AB	2005-08-26	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A077203-002	CHOLESTYRAMINE LIGHT	EQ 4GM RESIN/SCOOPFUL	POWDER / ORAL	AB	2005-08-26	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A077203-001	CHOLESTYRAMINE LIGHT	EQ 4GM RESIN/PACKET	POWDER / ORAL	AB	2005-08-26	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A077203-002	CHOLESTYRAMINE LIGHT	EQ 4GM RESIN/SCOOPFUL	POWDER / ORAL	AB	2005-08-26	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A077203-001	CHOLESTYRAMINE LIGHT	EQ 4GM RESIN/PACKET	POWDER / ORAL	AB	2005-08-26	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A077203-002	CHOLESTYRAMINE LIGHT	EQ 4GM RESIN/SCOOPFUL	POWDER / ORAL	AB	2005-08-26	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A077203-001	CHOLESTYRAMINE LIGHT	EQ 4GM RESIN/PACKET	POWDER / ORAL	AB	2005-08-26	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A077203-002	CHOLESTYRAMINE LIGHT	EQ 4GM RESIN/SCOOPFUL	POWDER / ORAL	AB	2005-08-26	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A077203-001	CHOLESTYRAMINE LIGHT	EQ 4GM RESIN/PACKET	POWDER / ORAL	AB	2005-08-26	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A077203-002	CHOLESTYRAMINE LIGHT	EQ 4GM RESIN/SCOOPFUL	POWDER / ORAL	AB	2005-08-26	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A077203-001	CHOLESTYRAMINE LIGHT	EQ 4GM RESIN/PACKET	POWDER / ORAL	AB	2005-08-26	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A077203-002	CHOLESTYRAMINE LIGHT	EQ 4GM RESIN/SCOOPFUL	POWDER / ORAL	AB	2005-08-26	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A077203-001	CHOLESTYRAMINE LIGHT	EQ 4GM RESIN/PACKET	POWDER / ORAL	AB	2005-08-26	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A077203-002	CHOLESTYRAMINE LIGHT	EQ 4GM RESIN/SCOOPFUL	POWDER / ORAL	AB	2005-08-26	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A077203-001	CHOLESTYRAMINE LIGHT	EQ 4GM RESIN/PACKET	POWDER / ORAL	AB	2005-08-26	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A077203-002	CHOLESTYRAMINE LIGHT	EQ 4GM RESIN/SCOOPFUL	POWDER / ORAL	AB	2005-08-26	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A077203-001	CHOLESTYRAMINE LIGHT	EQ 4GM RESIN/PACKET	POWDER / ORAL	AB	2005-08-26	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A077203-002	CHOLESTYRAMINE LIGHT	EQ 4GM RESIN/SCOOPFUL	POWDER / ORAL	AB	2005-08-26	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A077203-001	CHOLESTYRAMINE LIGHT	EQ 4GM RESIN/PACKET	POWDER / ORAL	AB	2005-08-26	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A077203-002	CHOLESTYRAMINE LIGHT	EQ 4GM RESIN/SCOOPFUL	POWDER / ORAL	AB	2005-08-26	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A077203-001	CHOLESTYRAMINE LIGHT	EQ 4GM RESIN/PACKET	POWDER / ORAL	AB	2005-08-26	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A077203-002	CHOLESTYRAMINE LIGHT	EQ 4GM RESIN/SCOOPFUL	POWDER / ORAL	AB	2005-08-26	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A077203-001	CHOLESTYRAMINE LIGHT	EQ 4GM RESIN/PACKET	POWDER / ORAL	AB	2005-08-26	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A077203-002	CHOLESTYRAMINE LIGHT	EQ 4GM RESIN/SCOOPFUL	POWDER / ORAL	AB	2005-08-26	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A077203-001	CHOLESTYRAMINE LIGHT	EQ 4GM RESIN/PACKET	POWDER / ORAL	AB	2005-08-26	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A077203-002	CHOLESTYRAMINE LIGHT	EQ 4GM RESIN/SCOOPFUL	POWDER / ORAL	AB	2005-08-26	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A077203-001	CHOLESTYRAMINE LIGHT	EQ 4GM RESIN/PACKET	POWDER / ORAL	AB	2005-08-26	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A077203-002	CHOLESTYRAMINE LIGHT	EQ 4GM RESIN/SCOOPFUL	POWDER / ORAL	AB	2005-08-26	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A077203-001	CHOLESTYRAMINE LIGHT	EQ 4GM RESIN/PACKET	POWDER / ORAL	AB	2005-08-26	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	A077203-002	CHOLESTYRAMINE LIGHT	EQ 4GM RESIN/SCOOPFUL	POWDER / ORAL	AB	2005-08-26	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A077203-001	CHOLESTYRAMINE LIGHT	EQ 4GM RESIN/PACKET	POWDER / ORAL	AB	2005-08-26	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A077203-002	CHOLESTYRAMINE LIGHT	EQ 4GM RESIN/SCOOPFUL	POWDER / ORAL	AB	2005-08-26	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A077203-001	CHOLESTYRAMINE LIGHT	EQ 4GM RESIN/PACKET	POWDER / ORAL	AB	2005-08-26	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	A077203-002	CHOLESTYRAMINE LIGHT	EQ 4GM RESIN/SCOOPFUL	POWDER / ORAL	AB	2005-08-26	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A077203-001	CHOLESTYRAMINE LIGHT	EQ 4GM RESIN/PACKET	POWDER / ORAL	AB	2005-08-26	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	A077203-002	CHOLESTYRAMINE LIGHT	EQ 4GM RESIN/SCOOPFUL	POWDER / ORAL	AB	2005-08-26	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A077203-001	CHOLESTYRAMINE LIGHT	EQ 4GM RESIN/PACKET	POWDER / ORAL	AB	2005-08-26	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	A077203-002	CHOLESTYRAMINE LIGHT	EQ 4GM RESIN/SCOOPFUL	POWDER / ORAL	AB	2005-08-26	`74a2ff9319b5…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 3 · 86 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-09-14 22:38:34	2026-08	A077203-001	AB	1	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A077203-002	AB	1	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	A077203-001	AB	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A077203-002	AB	1	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A077203-001	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A077203-002	AB	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A077203-001	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A077203-002	AB	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A077203-001	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A077203-002	AB	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A077203-001	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A077203-002	AB	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A077203-001	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A077203-002	AB	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A077203-001	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A077203-002	AB	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A077203-001	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A077203-002	AB	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A077203-001	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A077203-002	AB	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A077203-001	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A077203-002	AB	1	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A077203-001	AB	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A077203-002	AB	1	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A077203-001	AB	1	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A077203-002	AB	1	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A077203-001	AB	1	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A077203-002	AB	1	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A077203-001	AB	1	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A077203-002	AB	1	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A077203-001	AB	1	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	A077203-002	AB	1	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A077203-001	AB	1	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A077203-002	AB	1	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A077203-001	AB	1	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	A077203-002	AB	1	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A077203-001	AB	1	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	A077203-002	AB	1	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A077203-001	AB	1	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	A077203-002	AB	1	`74a2ff9319b5…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

Additional Listing Data#

Finished product: Yes
Brand name base: Cholestyramine
Listing expiration: 2027-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
CHOLESTYRAMINE	4 g/5g

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
4B33BGI082	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 2 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
848943	Internal RxNorm lookup
1801279	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
b0c65058-22c3-4f57-9b61-9bc6fcd6e240	Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
bafdcfac-da3a-43c4-81f4-296b60084636	Product name	6	20250623

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
49884-466-50	Cholestyramine	210 g in 1 BOTTLE	POWDER, FOR SUSPENSION	210	17
49884-466-63	Cholestyramine	5 g in 1 PACKET	POWDER, FOR SUSPENSION	5	17
49884-466-65	Cholestyramine	60 in 1 CARTON	POWDER, FOR SUSPENSION	60	17
49884-466-67	Cholestyramine	210 g in 1 CAN	POWDER, FOR SUSPENSION	210	17

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
49884-466-63	EA - Each	49884-466	351a1149-86f1-4288-b604-9217b9406938	1	2013-02-13
49884-466-65	EA - Each	49884-466	5a41c75a-2a3e-4aaa-a475-c6c3662c23bd	1	2012-07-24
49884-466-67	GM - Gram	49884-466	5c807746-cd6b-4ff8-9590-61a6a3c67af5	1	2012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
CHOLESTYRAMINE	ACTIVE INGREDIENT	4B33BGI082	CHOLESTYRAMINE POWDER, FOR SUSPENSION [PAR PHARMACEUTICAL, INC.]	7
CHOLESTYRAMINE	ACTIVE MOIETY	4B33BGI082	CHOLESTYRAMINE POWDER, FOR SUSPENSION [PAR PHARMACEUTICAL, INC.]	7
ACACIA	INACTIVE INGREDIENT	5C5403N26O	CHOLESTYRAMINE POWDER, FOR SUSPENSION [PAR PHARMACEUTICAL, INC.]	7
ANHYDROUS CITRIC ACID	INACTIVE INGREDIENT	XF417D3PSL	CHOLESTYRAMINE POWDER, FOR SUSPENSION [PAR PHARMACEUTICAL, INC.]	7
ASPARTAME	INACTIVE INGREDIENT	Z0H242BBR1	CHOLESTYRAMINE POWDER, FOR SUSPENSION [PAR PHARMACEUTICAL, INC.]	7
D&C YELLOW NO. 10	INACTIVE INGREDIENT	35SW5USQ3G	CHOLESTYRAMINE POWDER, FOR SUSPENSION [PAR PHARMACEUTICAL, INC.]	7
FD&C RED NO. 40	INACTIVE INGREDIENT	WZB9127XOA	CHOLESTYRAMINE POWDER, FOR SUSPENSION [PAR PHARMACEUTICAL, INC.]	7
FD&C YELLOW NO. 6	INACTIVE INGREDIENT	H77VEI93A8	CHOLESTYRAMINE POWDER, FOR SUSPENSION [PAR PHARMACEUTICAL, INC.]	7
MALTODEXTRIN	INACTIVE INGREDIENT	7CVR7L4A2D	CHOLESTYRAMINE POWDER, FOR SUSPENSION [PAR PHARMACEUTICAL, INC.]	7
POLYSORBATE 80	INACTIVE INGREDIENT	6OZP39ZG8H	CHOLESTYRAMINE POWDER, FOR SUSPENSION [PAR PHARMACEUTICAL, INC.]	7
PROPYLENE GLYCOL ALGINATE	INACTIVE INGREDIENT	26CD3J2R0C	CHOLESTYRAMINE POWDER, FOR SUSPENSION [PAR PHARMACEUTICAL, INC.]	7
SUCROSE	INACTIVE INGREDIENT	C151H8M554	CHOLESTYRAMINE POWDER, FOR SUSPENSION [PAR PHARMACEUTICAL, INC.]	7
XANTHAN GUM	INACTIVE INGREDIENT	TTV12P4NEE	CHOLESTYRAMINE POWDER, FOR SUSPENSION [PAR PHARMACEUTICAL, INC.]	7
CHOLESTYRAMINE	ACTIVE INGREDIENT	4B33BGI082	CHOLESTYRAMINE POWDER, FOR SUSPENSION [PHYSICIANS TOTAL CARE, INC.]	1
CHOLESTYRAMINE	ACTIVE MOIETY	4B33BGI082	CHOLESTYRAMINE POWDER, FOR SUSPENSION [PHYSICIANS TOTAL CARE, INC.]	1
ACACIA	INACTIVE INGREDIENT	5C5403N26O	CHOLESTYRAMINE POWDER, FOR SUSPENSION [PHYSICIANS TOTAL CARE, INC.]	1
ASPARTAME	INACTIVE INGREDIENT	Z0H242BBR1	CHOLESTYRAMINE POWDER, FOR SUSPENSION [PHYSICIANS TOTAL CARE, INC.]	1
CITRIC ACID ANHYDROUS	INACTIVE INGREDIENT	XF417D3PSL	CHOLESTYRAMINE POWDER, FOR SUSPENSION [PHYSICIANS TOTAL CARE, INC.]	1
D&C YELLOW NO. 10	INACTIVE INGREDIENT	35SW5USQ3G	CHOLESTYRAMINE POWDER, FOR SUSPENSION [PHYSICIANS TOTAL CARE, INC.]	1
FD&C RED NO. 40	INACTIVE INGREDIENT	WZB9127XOA	CHOLESTYRAMINE POWDER, FOR SUSPENSION [PHYSICIANS TOTAL CARE, INC.]	1
FD&C YELLOW NO. 6	INACTIVE INGREDIENT	H77VEI93A8	CHOLESTYRAMINE POWDER, FOR SUSPENSION [PHYSICIANS TOTAL CARE, INC.]	1
MALTODEXTRIN	INACTIVE INGREDIENT	7CVR7L4A2D	CHOLESTYRAMINE POWDER, FOR SUSPENSION [PHYSICIANS TOTAL CARE, INC.]	1
POLYSORBATE 80	INACTIVE INGREDIENT	6OZP39ZG8H	CHOLESTYRAMINE POWDER, FOR SUSPENSION [PHYSICIANS TOTAL CARE, INC.]	1
PROPYLENE GLYCOL ALGINATE	INACTIVE INGREDIENT	26CD3J2R0C	CHOLESTYRAMINE POWDER, FOR SUSPENSION [PHYSICIANS TOTAL CARE, INC.]	1
SUCROSE	INACTIVE INGREDIENT	C151H8M554	CHOLESTYRAMINE POWDER, FOR SUSPENSION [PHYSICIANS TOTAL CARE, INC.]	1
XANTHAN GUM	INACTIVE INGREDIENT	TTV12P4NEE	CHOLESTYRAMINE POWDER, FOR SUSPENSION [PHYSICIANS TOTAL CARE, INC.]	1

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
49884-466	CHOLESTYRAMINE POWDER, FOR SUSPENSION [ENDO USA, INC.]	16	Current NDC, Legacy NDC, 4 package rows	20241212_b0c65058-22c3-4f57-9b61-9bc6fcd6e240.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 4 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Cholestyramine	CHOLESTYRAMINE	Bryant Ranch Prepack	b26a13e9-42a2-4869-a00a-672bb1ac4742	2026-07-13	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 077203 application number: ANDA077203
Cholestyramine	CHOLESTYRAMINE	Par Health USA, LLC	b0c65058-22c3-4f57-9b61-9bc6fcd6e240	2026-06-15	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 077203 application number: ANDA077203 ndc (package): 49884-466-65 ndc (product): 49884-466 ndc11 (package): 49884046665
QUESTRAN	CHOLESTYRAMINE	Par Health USA, LLC	362ddd91-a63f-4ec6-841a-75785dd208c8	2026-04-17	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 077203 application number: ANDA077203
Cholestyramine	CHOLESTYRAMINE	Bryant Ranch Prepack	c58d6bd9-0273-4c16-8533-495170413d8c	2024-08-23	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 077203 application number: ANDA077203

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
4B33BGI082	CHOLESTYRAMINE	11041-12-6	CHOLESTYRAMINE

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
1801279	cholestyramine Sugar-Free 4 GM Powder for Oral Suspension	PSN	b26a13e9-42a2-4869-a00a-672bb1ac4742	104
1801279	Sugar-Free cholestyramine resin 4000 MG Powder for Oral Suspension	SCD	b26a13e9-42a2-4869-a00a-672bb1ac4742	104
1801279	cholestyramine Sugar-Free 4 GM Powder for Oral Suspension	SY	b26a13e9-42a2-4869-a00a-672bb1ac4742	104
1801279	cholestyramine Sugar-Free 4 GM Powder for Oral Suspension	PSN	c58d6bd9-0273-4c16-8533-495170413d8c	101
1801279	Sugar-Free cholestyramine resin 4000 MG Powder for Oral Suspension	SCD	c58d6bd9-0273-4c16-8533-495170413d8c	101
1801279	cholestyramine Sugar-Free 4 GM Powder for Oral Suspension	SY	c58d6bd9-0273-4c16-8533-495170413d8c	101
848943	cholestyramine resin 4 GM Powder for Oral Suspension	PSN	b0c65058-22c3-4f57-9b61-9bc6fcd6e240	17
1801279	cholestyramine Sugar-Free 4 GM Powder for Oral Suspension	PSN	b0c65058-22c3-4f57-9b61-9bc6fcd6e240	17
848943	cholestyramine resin 4000 MG Powder for Oral Suspension	SCD	b0c65058-22c3-4f57-9b61-9bc6fcd6e240	17
1801279	Sugar-Free cholestyramine resin 4000 MG Powder for Oral Suspension	SCD	b0c65058-22c3-4f57-9b61-9bc6fcd6e240	17
848943	cholestyramine resin 4 GM per 9 GM Powder for Oral Suspension	SY	b0c65058-22c3-4f57-9b61-9bc6fcd6e240	17
848943	cholestyramine resin 4 GM Powder for Oral Suspension	SY	b0c65058-22c3-4f57-9b61-9bc6fcd6e240	17
1801279	cholestyramine Sugar-Free 4 GM Powder for Oral Suspension	SY	b0c65058-22c3-4f57-9b61-9bc6fcd6e240	17
848943	cholestyramine resin 4 GM Powder for Oral Suspension	PSN	2835b6f5-93da-4554-9d84-79132fd928ee	1
1801279	cholestyramine Sugar-Free 4 GM Powder for Oral Suspension	PSN	2835b6f5-93da-4554-9d84-79132fd928ee	1
848943	cholestyramine resin 4000 MG Powder for Oral Suspension	SCD	2835b6f5-93da-4554-9d84-79132fd928ee	1
1801279	Sugar-Free cholestyramine resin 4000 MG Powder for Oral Suspension	SCD	2835b6f5-93da-4554-9d84-79132fd928ee	1
848943	cholestyramine resin 4 GM per 9 GM Powder for Oral Suspension	SY	2835b6f5-93da-4554-9d84-79132fd928ee	1
848943	cholestyramine resin 4 GM Powder for Oral Suspension	SY	2835b6f5-93da-4554-9d84-79132fd928ee	1
1801279	cholestyramine Sugar-Free 4 GM Powder for Oral Suspension	SY	2835b6f5-93da-4554-9d84-79132fd928ee	1

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
49884-466-65	49884046665	60 PACKET in 1 CARTON (49884-466-65) / 5 g in 1 PACKET (49884-466-63)	60 packet	2005-09-15	0000-00-00	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Cholestyramine for Oral Suspension	Bryant Ranch Prepack	2026-07-13	HUMAN PRESCRIPTION DRUG LABEL	105
Cholestyramine for Oral Suspension	Par Health USA, LLC	2026-06-15	HUMAN PRESCRIPTION DRUG LABEL	18
Cholestyramine for Oral Suspension	Bryant Ranch Prepack	2024-08-23	HUMAN PRESCRIPTION DRUG LABEL	101
Cholestyramine for Oral Suspension	Bryant Ranch Prepack	2024-01-10	HUMAN PRESCRIPTION DRUG LABEL	104
Cholestyramine - Physicians Total Care, Inc.	Physicians Total Care, Inc.	2010-04-28	HUMAN PRESCRIPTION DRUG LABEL	1